This interesting session, Chaired by M. Steinlin and J. Putaala, covered the most relevant areas of cerebrovascular disease in the young age, pointing out well calibrated updates on selected topics and take-home messages oriented to the clinical practice.
First speaker of the session, Dr. Annette Fromm from Bergen (Norway) showed a complete overview of diagnostic pathways in young stroke patients, following literature proposals and the experience of the ongoing NOR-SYS study, addressing in particular this item, with a special focus on under evaluated role of “classical” vascular risk factors in young people and sub-clinical atherosclerosis with a systemic screening screening approach.
The second speaker, L. Rutten-Jacobs, pointed out the consequences of this underestimation of traditional vascular risk factors in young people with stroke, using the results of FUTURE study and showing us the complex but non favourable long term outcome of TIA/stroke in young people mostly regarding stroke recurrence, cognitive consequences, loss of quality of life, unemployment rate and so on.
The other speakers, D.d.A.D. de Sousa, A. Singhal, and F. Heinen, gave us a significant update about new evidence and active research fields about:
– cerebral venous thrombosis, whose epidemiology, diagnosis, risk factors and treatment are changing or more deeply investigated
– reversible cerebral vasoconstriction syndrome and the overlapping phenotype and pathophysiology with thunderclap headache and primary central nervous system vasculitis
– pediatric stroke pathways, presenting a standardized management plan and showing the difficult differential diagnosis of cerebrovascular disease in children.